BTS Stockholm 2024: Aesthetic medicine in transition

Nordberg Medical had the pleasure of being a Gold Sponsor at Beauty Through Science (BTS),  a must-attend event for the aesthetic medicine industry, taking place in our home city of Stockholm from 30 May to 1 June 2024. For three days, the biggest names in the industry met at the largest aesthetics congress in Scandinavia.

In its 20-year history, BTS has grown from 150 participants to over 1,000 professionals from more than 50 countries in recent editions. This impressive growth reflects the quality and influence of a congress characterised by its focus on innovation and scientific excellence. The continuous support from the industry enables the presence of a large and renowned panel of experts, guaranteeing a first-class scientific standard. The topic of this year: regenerative medicine and natural rejuvenation techniques.

The three-day conference offered a dual programme, surgical and non-surgical, with 45 leading aesthetic medicine experts from around the world. A unique format offering the opportunity to learn about the latest techniques, protocols, and emerging technologies.

The Nordberg Medical team attended BTS to showcase its latest innovations in regenerative medicine. As a further step in our efforts to endorse our science, Nordberg Medical organised several sessions on regenerative medicine. We discussed inflammatory stress versus active regeneration, alternatives to natural rejuvenation with zero footprint and an exclusive symposium with our physicians to discuss the scientific solutions to natural regeneration. These sessions provided an in-depth look at the most advanced techniques and technologies in aesthetic and regenerative medicine and provided attendees with valuable knowledge that can enrich their daily medical practices

To provide effective and ethical solutions, every Nordberg Medical product is developed specifically for patient safety and efficacy. By listening to the needs and concerns of professionals, the company emphasises its commitment to developing unique, high-quality solutions that improve patients’ lives. This learning-centred approach has enabled us to identify new avenues and challenges in regenerative medicine, an area where collaboration with the medical community is critical to achieving excellence.

Nordberg Medical is based at the Karolinska Institute Science Park in Stockholm and offers high-quality biofunctional materials produced using cutting-edge biotechnology. JULÄINE, the brand’s first CE-certified product available in Europe and manufactured in Sweden, is an example of its commitment to advancing regenerative medicine in a responsible and dedicated way to improve people’s comfort and well-being.

Nordberg Medical specialises in biotechnological production processes and the commercialisation of cutting-edge, future-oriented biomaterials and is in the midst of international expansion. The company already operates in Sweden, Spain, Italy, France and Germany and plans to expand into other European countries during 2024.